Latest News

FDA approves Blueprint Medicines’ precision therapy for rare form of gastrointestinal cancer


Text FDA Approved appearing behind ripped brown paper.

The agency on Thursday approved Ayvakit (avapritinib) for gastrointestinal stromal tumor, or GIST, that harbors a PDGFRa exon 18 mutation. Still, identifying patients could be the biggest challenge, an analyst wrote.

Source link

Related posts

Medical News Today: Repairing leaky blood-brain barrier may rejuvenate brain function

Newsemia

Evaluate Ltd. revolutioniert mit der Einführung von Product Specific PTRS die Risikobewertung bei Forschung und Entwicklung in der Pharmaindustrie

Newsemia

7 Effective Ways To Improve Your Mental Health

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World